Literature DB >> 15994305

Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39.

Fumika Sakaue1, Taro Saito, Yutaka Sato, Akiko Asada, Koichi Ishiguro, Masato Hasegawa, Shin-ichi Hisanaga.   

Abstract

One of the major pathological hallmarks of Alzheimer disease is neurofibrillary tangles. Neurofibrillary tangles are bundles of paired helical filaments composed of hyperphosphorylated tau. Cyclin-dependent kinase 5 (Cdk5) is one of the tau protein kinases that increase paired helical filament epitopes in tau by phosphorylation. Recently, various mutations of tau have been identified in frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). Here, we investigated the phosphorylation of FTDP-17 mutant tau proteins, K257T, P301L, P301S, and R406W, by Cdk5 complexed with p35, p25, or p39 in vitro and in cultured cells. The extent of phosphorylation by all Cdk5 species was slightly lower in mutant tau than in wild-type tau. Major phosphorylation sites, including Ser202, Ser235, and Ser404, were the same among the wild-type, K257T, P301L, and P301S tau proteins phosphorylated by any Cdk5. On the other hand, R406W tau was less phosphorylated at Ser404 than were the other variants. This was not due to the simple replacement of amino acid Arg406 with Trp close to the phosphorylation site, because Ser404 in a R406W peptide was equally phosphorylated in a wild-type peptide. The decreased phosphorylation of mutant tau by Cdk5s was canceled when tau protein bound to microtubules was phosphorylated. These results indicate that FTDP-17 mutations do not affect the phosphorylatability of tau by Cdk5 complexed with p35, p25, or p39 and may explain part of the discrepancy reported previously between in vivo and in vitro phosphorylation of FTDP-17 tau mutants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994305     DOI: 10.1074/jbc.M504792200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

Review 2.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

3.  Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.

Authors:  Aurélie de Thonel; Saima E Ferraris; Hanna-Mari Pallari; Susumu Y Imanishi; Vitaly Kochin; Tomohisa Hosokawa; Shin-ichi Hisanaga; Cecilia Sahlgren; John E Eriksson
Journal:  Mol Biol Cell       Date:  2010-03-03       Impact factor: 4.138

4.  Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease.

Authors:  Kourosh Shahpasand; Isao Uemura; Taro Saito; Tsunaki Asano; Kenji Hata; Keitaro Shibata; Yoko Toyoshima; Masato Hasegawa; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

5.  MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.

Authors:  Beatriz E García-Gómez; Francisco J Fernández-Gómez; Encarnación Muñoz-Delgado; Luc Buée; David Blum; Cecilio J Vidal
Journal:  J Mol Neurosci       Date:  2015-12-23       Impact factor: 3.444

6.  No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.

Authors:  Dylan W Peterson; D Michael Ando; Daryl A Taketa; Hongjun Zhou; Fredrick W Dahlquist; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.

Authors:  Kensuke Yotsumoto; Taro Saito; Akiko Asada; Takayuki Oikawa; Taeko Kimura; Chiyoko Uchida; Koichi Ishiguro; Takafumi Uchida; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

8.  Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites.

Authors:  Taeko Kimura; Koji Tsutsumi; Masato Taoka; Taro Saito; Masami Masuda-Suzukake; Koichi Ishiguro; Florian Plattner; Takafumi Uchida; Toshiaki Isobe; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

9.  Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity.

Authors:  Jiqing Xu; Koji Tsutsumi; Kiyotaka Tokuraku; Katherine A Estes; Shin-ichi Hisanaga; Tsuneya Ikezu
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

10.  Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.

Authors:  Sayuko Kaminosono; Taro Saito; Fumitaka Oyama; Toshio Ohshima; Akiko Asada; Yoshitaka Nagai; Nobuyuki Nukina; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.